Sign in

CIK 0000818033 · Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
942875566
Phone
8582514400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-10-13 Quart Barry D Chief Executive Officer Grant or award · Restricted Stock Units +195,417 195,417
2021-10-13 POYHONEN JOHN President & CCO Option exercise +1,250 23,452
2021-10-13 POYHONEN JOHN President & CCO Shares withheld for taxes −433 $10.55 $5K 23,019
2021-10-13 POYHONEN JOHN President & CCO Option exercise · Restricted Stock Units −1,250 15,000
2021-10-13 POYHONEN JOHN President & CCO Grant or award · Employee Stock Option (Right to Buy) +92,200 92,200
2021-10-13 POYHONEN JOHN President & CCO Grant or award · Restricted Stock Units +55,320 55,320
2021-10-13 Peraza Lisa VP, Chief Accounting Officer Option exercise +552 14,388
2021-10-13 Peraza Lisa VP, Chief Accounting Officer Shares withheld for taxes −191 $10.55 $2K 14,197
2021-10-13 Peraza Lisa VP, Chief Accounting Officer Option exercise · Restricted Stock Units −552 6,625
2021-10-13 Peraza Lisa VP, Chief Accounting Officer Grant or award · Employee Stock Option (Right to Buy) +13,013 13,013
2021-10-13 Peraza Lisa VP, Chief Accounting Officer Grant or award · Restricted Stock Units +23,424 23,424
2021-10-13 MANHARD KIMBERLY EVP, Drug Development Option exercise +1,250 3,701
2021-10-13 MANHARD KIMBERLY EVP, Drug Development Shares withheld for taxes −433 $10.55 $5K 3,268
2021-10-13 MANHARD KIMBERLY EVP, Drug Development Option exercise · Restricted Stock Units −1,250 15,000
2021-10-13 MANHARD KIMBERLY EVP, Drug Development Grant or award · Employee Stock Option (Right to Buy) +92,200 92,200
2021-10-13 MANHARD KIMBERLY EVP, Drug Development Grant or award · Restricted Stock Units +55,320 55,320
2021-09-21 Christian Waage Director Sale −300 $12.31 $4K 3,500
2021-09-21 Johnson Craig A Director Sale −250 $12.30 $3K 3,090
2021-07-13 Szekeres David Leslie EVP, Chief Operating Officer Option exercise +1,250 3,597
2021-07-13 Szekeres David Leslie EVP, Chief Operating Officer Shares withheld for taxes −433 $13.48 $6K 3,164

Page 25 of 28 · 557 trades